Debiopharm Innovation Fund ^Investors

Debiopharm Innovation Fund is a strategic investor based in Lausanne, Vaud, Switzerland. Founded in 2012, the fund focuses on providing investments to companies and businesses in the biotech, pharma, and Biomed sectors. Operating primarily in Europe, Middle East, and Africa (EMEA), Debiopharm Innovation Fund has made strategic investments in notable companies such as Genialis, VeriSIM Life, WhiteLab Genomics, Altis Labs, Concr, Nucleai, and Iktos. With its location in Switzerland, a hub for innovation in the life sciences industry, the fund plays a significant role in fostering advancements and breakthroughs in the field.